HLA-A complexes with beta-2 microglobulin to present viral and tumor-derived peptides on antigen-presenting cells for recognition by alpha-beta T-cell receptor on CD8+ T cells, guiding antigen-specific T-cell immune response to eliminate cells. Here, CD8A is linked to neoplasm.